Observational studyInfection2025

Predictors of therapeutic exposure and pharmacokinetic variability of second-line anti-TB drugs in MDR-TB patients: a retrospective study.

Chilie Quncuo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.